about
The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications.[A CASE OF EOSINOPHILIC BRONCHIOLITIS COMPLICATED WITH BRONCHIAL ASTHMA AND CHRONIC EOSINOPHILIC PNEUMONIA].Blunted activation of Rho-kinase in yak pulmonary circulation.Small airway disease associated with Sjögren's syndrome: clinico-pathological correlations.Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia.Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer.Osteogenesis Imperfecta Associated with Dendriform Pulmonary Ossification.Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis.(18)F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancer.Mandibular metastasis as the first clinical indication of occult lung adenocarcinoma with multiple metastases: A case report.Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis.Multi-arterial infusion chemotherapy for non-small cell lung carcinoma--significance of detecting feeding arteries and tumor staining.Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases.Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancerExtracellular acidification-induced CXCL8 production through a proton-sensing receptor OGR1 in human airway smooth muscle cells: a response inhibited by dexamethasoneThe vertebral 3'-deoxy-3'-18F-fluorothymidine uptake predicts the hematological toxicity after systemic chemotherapy in patients with lung cancerPredictive value of integrated 18F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer
P50
Q34167415-6E4412BA-2CED-43B8-A98E-806D01A0FF1FQ40711037-2E07233F-D3AF-47B8-A115-464271F63036Q41810359-479AE7A9-40A8-4A0A-B663-78AA9F2B5094Q43941782-03876491-4117-44DF-8FFD-464C5224B964Q44673116-2B9E6531-D8BB-484D-AD5B-F9D3D4B27DA0Q46106801-9375EA6B-94F2-4B21-9172-1F05889FDB56Q47640288-564E8259-809E-4A5D-9CCB-740F1D740D01Q50436159-A9BE64FA-0F81-4F4B-A4F4-13576E5105ABQ50437296-578753D8-C205-45EA-ADF7-EBC8B018071DQ51727230-AE24EB04-56CC-41CF-8197-802F6FAD1779Q52593858-C7A11508-6296-455A-AB67-1BF878775F1DQ53239854-E167293A-2422-4BAD-808F-67D500F052B8Q53500872-8A4C71EF-C3EE-40F5-A6C6-8606105F2D83Q53512762-14922C51-4082-4CDA-8268-6CBC863F1FFDQ57453351-881AD390-A6EC-466B-9D98-8CCF3CE2CB54Q64260463-1D6D5DB1-784F-4B91-A817-2472C7F60F3CQ93016714-43E0E946-A3CE-40A2-9E9C-1B86741D245BQ94451603-12E44EC1-43D6-4469-B97E-ED93C5F24297
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yukihiro Umeda
@en
Yukihiro Umeda
@nl
type
label
Yukihiro Umeda
@en
Yukihiro Umeda
@nl
prefLabel
Yukihiro Umeda
@en
Yukihiro Umeda
@nl
P31
P496
0000-0002-9826-6856